Institutional investors purchased a net $505.7 thousand shares of RGEN during the quarter ended September 2015 and now own 92.50% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
COLUMBUS CIRCLE INVESTORS Bought 227.3 Thousand shares of Repligen Corp
MILLENNIUM MANAGEMENT LLC Bought 216.5 Thousand shares of Repligen Corp
WILLIAM BLAIR INVESTMENT MANAGEM... Bought 166.0 Thousand shares of Repligen Corp